Pro Share Advisors LLC Xeris Biopharma Holdings, Inc. Transaction History
Pro Share Advisors LLC
- $46.4 Billion
- Q3 2025
A detailed history of Pro Share Advisors LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 32,007 shares of XERS stock, worth $232,050. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,007
Previous 36,723
12.84%
Holding current value
$232,050
Previous $171,000
51.46%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding XERS
# of Institutions
236Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...